LIFR Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of LIFR monoclonal antibodies for investigating leukemia inhibitory factor receptor (LIFR) in various biological processes. LIFR monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LIFR is a key component in signaling pathways that regulate cell differentiation, survival, and proliferation, particularly in stem cell biology and immune responses. LIFR functions are essential for mediating the effects of leukemia inhibitory factor, playing a significant role in embryonic development and maintaining pluripotency in stem cells. Research focusing on LIFR mechanisms can advance understanding of various diseases, including cancer and autoimmune disorders. LIFR monoclonal antibodies enable precise detection and analysis of LIFR expression patterns across different cell types and tissues. Studying LIFR signaling pathways can reveal new therapeutic targets and treatment strategies. LIFR research continues to uncover important insights into cellular regulation and development. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge and developing innovative therapeutic approaches.